PERTH, Australia – Avita Medical Ltd. plans to submit its Recell spray-on-skin premarket approval application to the FDA in a few weeks following positive results from its pivotal trial.
PERTH, Australia – Avita Medical Ltd. plans to submit its Recell spray-on-skin premarket approval application to the FDA in a few weeks following positive results from its pivotal trial.
PERTH, Australia – Australia's biopharma and medical device industries breathed a collective sigh of relief that the Australian Government's 2017 budget announced May 9 left the much-loved R&D tax incentive untouched.
PERTH, Australia – The TGA is seeking industry comments on its proposal to beef up sanctions and penalties as part of its overhaul of drug and device regulations.
PERTH, Australia – Although CEOs of life sciences companies in Australia said that 2016 was their strongest year yet, that optimism was dampened by uncertainty surrounding government policy on R&D tax incentives, according to AusBiotech's annual CEO survey.
